Skandinaviska Enskilda Banken (SEB)
HAE icon

Skandinaviska Enskilda Banken (SEB)’s Haemonetics HAE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,400
Closed -$1.06M – 859
2023
Q4 		$1.06M Hold
12,400
– – 0.01% 689
2023
Q3 		$1.11M Sell
12,400
-2,600
-17% -$232K 0.01% 664
2023
Q2 		$1.28M Buy
15,000
+12,500
+500% +$1.06M 0.01% 659
2023
Q1 		$207K Buy
+2,500
New +$202K ﹤0.01% 826

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s HAE Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Haemonetics (HAE) in Q1 2024, closing a stake of 12,400 shares — an estimated $1.06M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in HAE in Q1 2023 and held it in 4 quarters. The position peaked at $1.28M in Q2 2023. 298 funds tracked by Wall St. Rank hold HAE as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Haemonetics position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 12,400 Haemonetics shares in Q1 2024, an estimated $1.06M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Haemonetics in Q1 2023 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Haemonetics position peaked at $1.28M in Q2 2023.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.